Viking Therapeutics, Inc.

Historical 13F Holders

Symbol
VKTX
CUSIP
92686J106
All holders as of
Q2 2026
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Shares Held, Excluding Options
Total Filers

13D/G Filers

Each filer's latest filing for 92686J106 since 12/18/2024, largest first.

Filer % of Class Filed
FMR LLC 13G/A
7.7% 11/5/2026
Event 9/30/2026
Vanguard Capital Management LLC 13G 5.1% 4/30/2026
Event 3/31/2026
Under 5%, checked the "5 percent or less" box, or amended by a later filing (2)
BlackRock, Inc. 13G/A 4.5% 4/23/2025
Event 3/31/2025
Vanguard Group Inc 13G/A 0% 3/27/2026
Event 3/13/2026

13F Holders by Quarter

Period Filers Shares, Excl. Options Value, Excl. Options
2026 Q3 228 22.0 M $718M
2026 Q2 443 75.8 M $2.96B
2026 Q1 420 73.3 M $2.43B
2025 Q4 435 72.1 M $2.54B
2025 Q3 382 71.3 M $1.87B
2025 Q2 402 76.2 M $2.02B
2025 Q1 382 77.8 M $1.88B
2024 Q4 421 82.0 M $3.30B
2024 Q3 436 83.9 M $5.25B
2024 Q2 399 80.4 M $4.26B
2024 Q1 389 80.1 M $6.57B
2023 Q4 205 76.4 M $1.42B
2023 Q3 187 77.1 M $854M
2023 Q2 199 74.8 M $1.21B
2023 Q1 188 66.5 M $1.11B
2022 Q4 135 34.3 M $321M
2022 Q3 109 26.6 M $72.4M
2022 Q2 118 26.7 M $77.3M
2022 Q1 143 31.0 M $93.8M
2021 Q4 141 36.2 M $166M
2021 Q3 135 37.8 M $238M
2021 Q2 140 37.9 M $227M
2021 Q1 146 41.0 M $260M
2020 Q4 147 37.7 M $213M
2020 Q3 143 39.6 M $230M
2020 Q2 143 40.2 M $290M
2020 Q1 140 39.4 M $184M
2019 Q4 147 39.8 M $319M
2019 Q3 148 40.7 M $280M
2019 Q2 159 45.1 M $375M
2019 Q1 169 45.8 M $455M
2018 Q4 168 46.9 M $359M
2018 Q3 157 43.5 M $758M
2018 Q2 120 31.8 M $302M
2018 Q1 66 20.9 M $91.4M
2017 Q4 33 9.34 M $37.9M
2017 Q3 18 2.02 M $3.85M
2017 Q2 12 1.57 M $1.69M
2017 Q1 12 770 k $1.13M
2016 Q4 12 637 k $758k
2016 Q3 14 1.21 M $1.70M
2016 Q2 13 861 k $1.08M
2016 Q1 11 46.5 k $72.0k
2015 Q4 7 44.4 k $158k
2015 Q3 6 43.2 k $252k
2015 Q2 6 54.0 k $384k